Association of HY-restricting HLA class II alleles with pregnancy outcome in patients with recurrent miscarriage subsequent to a firstborn boy

Human Molecular Genetics

Volumn 18, Issue 9, 2009, Pages 1684-1691

  Nielsen, Henriette Svarre ^a   Steffensen, Rudi ^b   Varming, Kim ^b   Van Halteren, Astrid G S ^c   Spierings, Eric ^c,d   Ryder, Lars P ^a   Goulmy, Els ^c   Christiansen, Ole Jarne ^a  

^a Rigshospitalet   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HISTOCOMPATIBILITY ANTIGEN; HLA A ANTIGEN; HLA ANTIGEN CLASS 2; HLA B ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; HLA DR3 ANTIGEN; HLA DR5 ANTIGEN; HY ANTIGEN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; IMMUNOLOGICAL TOLERANCE; LIVE BIRTH; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; PREGNANCY OUTCOME; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT ABORTION; RISK ASSESSMENT;

ABORTION, HABITUAL; FEMALE; H-Y ANTIGEN; HISTOCOMPATIBILITY ANTIGENS CLASS II; HISTOCOMPATIBILITY, MATERNAL-FETAL; HUMANS; LIVE BIRTH; MALE; PREGNANCY; PREGNANCY OUTCOME; SEX CHARACTERISTICS;

EID: 64549147053     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddp077     Document Type: Article

References (37)

1. Creasy, R. (1988) Cytogenetics of spontaneous abortion in humans. In Beard, RW and Sharp, F. (eds): Early pregnancy loss: Mechanisms and treatment. London, Springer, pp. 293-304.
2. Christiansen, O.B., Kolte, A.M. and Nielsen, H.S. (2006) Secondary recurrent miscarriage - a unique entity with respect to etiology and treatment. Curr. Women Health Rev., 2, 119-123.
3. Christiansen, O.B., Pedersen, B., Rosgaard, A. and Husth, M. (2002) A randomized, double-blind, placebo-controlled trial of intravenous immunoglobulin in the prevention of recurrent miscarriage: Evidence for a therapeutic effect in women with secondary recurrent miscarriage. Hum. Reprod., 17, 809-816.
4. Christiansen, O.B., Pedersen, B., Nielsen, H.S. and Nybo Andersen, A.M. (2004) Impact of the sex of first child on the prognosis in secondary recurrent miscarriage. Hum. Reprod., 19, 2946-2951.
5. Nielsen, H.S., Andersen, A.M., Kolte, A.M. and Christiansen, O.B. (2008) A firstborn boy is suggestive of a strong prognostic factor in secondary recurrent miscarriage: A confirmatory study. Fertil. Steril., 89, 907-911.
6. de, B.M., Bakker, A., van Rood, J.J., Van der, W.F. and Goulmy, E. (1992) Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens. J. Immunol., 149, 1788-1794.
7. Hambach, L., Spierings, E. and Goulmy, E. (2007) Risk assessment in haematopoietic stem cell transplantation: Minor histocompatibility antigens. Best Pract. Res. Clin. Haematol., 20, 171-187.
8. Kollman, C., Howe, C.W., Anasetti, C., Antin, J.H., Davies, S.M., Filipovich, A.H., Hegland, J., Kamani, N., Kernan, N.A., King, R. et al. (2001) Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: The effect of donor age. Blood, 98, 2043-2051.
9. Loren, A.W., Bunin, G.R., Boudreau, C., Champlin, R.E., Cnaan, A., Horowitz, M.M., Loberiza, F.R. and Porter, D.L. (2006) Impact of donor and recipient sex and parity on outcomes of HLA-identical sibling allogeneic hematopoietic stem cell transplantation. Biol. Blood Marrow Transplant., 12, 758-769.
10. Nielsen, H.S., Mortensen, L., Nygaard, U., Schnor, O., Christiansen, O.B. and Andersen, A.M. (2008) Brothers and reduction of the birth weight of later-born siblings. Am. J. Epidemiol., 167, 480-484.
11. Spierings, E., Vermeulen, C.J., Vogt, M.H., Doerner, L.E., Falkenburg, J.H., Mutis, T. and Goulmy, E. (2003) Identification of HLA class II-restricted H-Y-specific T-helper epitope evoking CD4+ T-helper cells in H-Y-mismatched transplantation. Lancet, 362, 610-615.
12. van Els, C.A., Zantvoort, E., Jacobs, N., Bakker, A., van Rood, J.J. and Goulmy, E. (1990) Graft-versus-host disease associated T helper cell responses specific for minor histocompatibility antigens are mainly restricted by HLA-DR molecules. Bone Marrow Transplant., 5, 365-372.
13. Zelenika, D., Adams, E., Mellor, A., Simpson, E., Chandler, P., Stockinger, B., Waldmann, H. and Cobbold, S.P. (1998) Rejection of H-Y disparate skin grafts by monospecific CD4 Th1 and Th2 cells: No requirement for CD8+ T cells or B cells. J. Immunol., 161, 1868-1874.
14. van Els, C.A., D'Amaro, J., Pool, J., Blokland, E., Bakker, A., van Elsen, P.J., van Rood, J.J. and Goulmy, E. (1992) Immunogenetics of human minor histocompatibility antigens: Their polymorphism and immunodominance. Immunogenetics, 35, 161-165.
15. Laurin, D., Spierings, E., van der Veken, L.T., Hamrouni, A., Falkenburg, J.H., Souillet, G., Vermeulen, C., Farre, A., Galambrun, C., Rigal, D. et al. (2006) Minor histocompatibility antigen DDX3Y induces HLA-DQ5-restricted T cell responses with limited TCR-Vbeta usage both in vivo and in vitro. Biol. Blood Marrow Transplant., 12, 1114-1124.
16. James, E., Chai, J.G., Dewchand, H., Macchiarulo, E., Dazzi, F. and Simpson, E. (2003) Multiparity induces priming to male-specific minor histocompatibility antigen, HY, in mice and humans. Blood, 102 388-393.
17. Verdijk, R.M., Kloosterman, A., Pool, J., van de Keur, M., Naipal, A.M., van Halteren, A.G., Brand, A., Mutis, T. and Goulmy, E. (2004) Pregnancy induces minor histocompatibility antigen-specific cytotoxic T cells: implications for stem cell transplantation and immunotherapy. Blood 103, 1961-1964.
18. Gale, R.P., Bortin, M.M., van Bekkum, D.W., Biggs, J.C., Dicke, K.A., Gluckman, E., Good, R.A., Hoffmann, R.G., Kay, H.E. and Kersey, J.H. (1987) Risk factors for acute graft-versus-host disease. Br. J. Haematol., 67, 397-406.
19. Gratwohl, A., Hermans, J., Niederwieser, D., van, B.A., van Houwelingen, H.C. and Apperley, J. (2001) Female donors influence transplant-related mortality and relapse incidence in male recipients of sibling blood and marrow transplants. Hematol. J., 2, 363-370.
20. Atkinson, K., Farrell, C., Chapman, G., Downs, K., Penny, R. and Biggs, J. (1986) Female marrow donors increase the risk of acute graft-versus-host disease: Effect of donor age and parity and analysis of cell subpopulations in the donor marrow inoculum. Br. J. Haematol. 63, 231-239.
21. Carlens, S., Ringden, O., Remberger, M., Lonnqvist, B., Hagglund, H., Klaesson, S., Mattsson, J., Svahn, B.M., Winiarski, J., Ljungman, P. and Aschan, J. (1998) Risk factors for chronic graft-versus-host disease after bone marrow transplantation: A retrospective single centre analysis. Bone Marrow Transplant., 22, 755-761.
22. Adams, K.M., Yan, Z., Stevens, A.M. and Nelson, J.L. (2007) The changing maternal 'self' hypothesis: A mechanism for maternal tolerance of the fetus. Placenta, 28, 378-382.
23. Huppertz, B., Kadyrov, M. and Kingdom, J.C. (2006) Apoptosis and its role in the trophoblast. Am. J. Obstet. Gynecol., 195, 29-39.
24. Steinman, R.M., Hawiger, D. and Nussenzweig, M.C. (2003) Tolerogenic dendritic cells. Annu. Rev. Immunol., 21, 685-711.
25. Gerber, S., Vardhana, S., Meagher-Villemure, K., Vial, Y., Hohlfeld, P. and Witkin, S.S. (2005) Association between fetal interleukin-1 receptor antagonist gene polymorphism and unexplained fetal death. Am. J. Obstet. Gynecol., 193, 1472-1477.
26. Germain, S.J., Sacks, G.P., Sooranna, S.R., Sargent, I.L. and Redman, C.W. (2007) Systemic inflammatory priming in normal pregnancy and preeclampsia: The role of circulating syncytiotrophoblast microparticles. J. Immunol., 178, 5949-5956.
27. Girardi, G., Yarilin, D., Thurman, J.M., Holers, V.M. and Salmon, J.E. (2006) Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction. J. Exp. Med., 203, 2165-2175.
28. Goswami, D., Tannetta, D.S., Magee, L.A., Fuchisawa, A., Redman, C.W., Sargent, I.L. and von Dadelszen, P. (2006) Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction. Placenta, 27 56-61.
29. Ariga, H., Ohto, H., Busch, M.P., Imamura, S., Watson, R., Reed, W. and Lee, T.H. (2001) Kinetics of fetal cellular and cell-free DNA in the maternal circulation during and after pregnancy: Implications for noninvasive prenatal diagnosis. Transfusion, 41, 1524-1530.
30. Bianchi, D.W., Zickwolf, G.K., Weil, G.J., Sylvester, S. and DeMaria, M.A. (1996) Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc. Natl Acad. Sci. USA, 93, 705-708.
31. Khosrotehrani, K., Johnson, K.L., Lau, J., Dupuy, A., Cha, D.H. and Bianchi, D.W. (2003) The influence of fetal loss on the presence of fetal cell microchimerism: A systematic review. Arthritis Rheum., 48, 3237-3241.
32. Leung, T.N., Zhang, J., Lau, T.K., Chan, L.Y. and Lo, Y.M. (2001) Increased maternal plasma fetal DNA concentrations in women who eventually develop preeclampsia. Clin. Chem., 47, 137-139.
33. Lo, Y.M., Leung, T.N., Tein, M.S., Sargent, I.L., Zhang, J., Lau, T.K., Haines, C.J. and Redman, C.W. (1999) Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin. Chem., 45, 184-188.
34. Zhong, X.Y., Holzgreve, W. and Hahn, S. (2001) Circulatory fetal and maternal DNA in pregnancies at risk and those affected by preeclampsia. Ann. N. Y. Acad. Sci., 945, 138-140.
35. Leung, T.N., Zhang, J., Lau, T.K., Hjelm, N.M. and Lo, Y.M. (1998) Maternal plasma fetal DNA as a marker for preterm labour. Lancet, 352, 1904-1905.
36. Zhong, X.Y., Steinborn, A., Sohn, C., Holzgreve, W. and Hahn, S. (2006) High levels of circulatory erythroblasts and cell-free DNA prior to intrauterine fetal death. Prenat. Diagn., 26, 1272-1273.
37. Nielsen, H.S. and Christiansen, O.B. (2005) Prognostic impact of anticardiolipin antibodies in women with recurrent miscarriage negative for the lupus anticoagulant. Hum. Reprod., 20, 1720-1728.